Insider Transactions in Q1 2023 at Salarius Pharmaceuticals, Inc. (SLRX)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 13
2023
|
Mark J Rosenblum Exec VP Finance, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
6,432
+22.74%
|
-
|
|
Feb 13
2023
|
David J. Arthur Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,300
+22.95%
|
-
|
|
Jan 03
2023
|
Jonathan I Lieber Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,440
+32.88%
|
-
|
|
Jan 03
2023
|
Paul Lammers Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,440
+45.6%
|
-
|
|
Jan 03
2023
|
Arnold C Hanish Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,440
+50.0%
|
-
|
|
Jan 03
2023
|
Bruce J Mc Creedy Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,440
+44.61%
|
-
|
|
Jan 03
2023
|
William K. Mc Vicar Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,440
+44.61%
|
-
|
|
Jan 03
2023
|
Tess Burleson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,440
+34.6%
|
-
|
|
Jan 03
2023
|
David J. Arthur Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+37.23%
|
-
|
|
Jan 03
2023
|
Mark J Rosenblum Exec VP Finance, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
8,000
+34.16%
|
-
|